# The Study for Evaluating the Clinical Effectiveness and Safety of Respiratory Rehabilitation Software 'Redpill Breath'(COPD, Asthma, Lung Cancer, Etc.)

> **NCT05299385** · PHASE3 · UNKNOWN · sponsor: **Lifesemantics Corp.** · enrollment: 100 (estimated)

## Conditions studied

- Respiratory System Disease
- Chronic Obstructive Pulmonary Disease
- Asthma Copd
- Lung Cancer
- Lung Diseases
- Pulmonary Rehabilitation
- Respiratory Rehabilitation
- Home Based Rehabilitation
- Mobile Application
- Rehabilitation

## Interventions

- **BEHAVIORAL:** Conventional rehabilition treatment(e.g leaflet) educated by hospital
- **DEVICE:** Digital treatment based on Respiratory Rehabilitation Software

## Key facts

- **NCT ID:** NCT05299385
- **Lead sponsor:** Lifesemantics Corp.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-01-13
- **Primary completion:** 2022-03-28
- **Final completion:** 2022-06-30
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2022-03-29

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05299385

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05299385, "The Study for Evaluating the Clinical Effectiveness and Safety of Respiratory Rehabilitation Software 'Redpill Breath'(COPD, Asthma, Lung Cancer, Etc.)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05299385. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*